Financial results for the period ended Jun 30, 2026
As filed · Indoco Remedies Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
EarningsMajormateriality 77 out of 100
What happened
FactThe Board of Directors of Indoco approved the Unaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June, 2026 during a meeting held on 28th July, 2026. A Limited Review Report with an unmodified opinion from the Statutory Auditors was also provided. The meeting commenced at 10:45 a.m. and concluded at 11:45 a.m.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- Our objective is to repay INR110 crores this year and another INR150 crores in next year. (management committed by FY27)
Evidence
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +4 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%